Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Prospective Single-Center Cohort Study

NCT07355088 is registered in ClinicalTrials.gov with Xinjiang Medical University as lead sponsor.

NCT NCT07355088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07355088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Prospective Single-Center Cohort Study
Lead sponsor
Xinjiang Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
March 1, 2028
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, heart failure with mildly reduced ejection fraction (hfmref), heart failure with preserved ejection fraction (hfpef), heart failure with reduced ejection fraction (hfref)